Revance Therapeutics, Inc. Lease Agreements
7 Contracts & Agreements
- Third Amendment to Lease dated January 13, 2023, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP (Filed With SEC on May 9, 2023)
- Second Amendment to Lease, dated July 1, 2021 by and between Revance Therapeutics, Inc and 1222 Demonbreun, LP (Filed With SEC on November 9, 2021)
- Amendment to Lease, effective as of January 4, 2021, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP (Filed With SEC on February 25, 2021)
- Office Lease Agreement dated November 19, 2020 (Filed With SEC on November 20, 2020)
- Fifth Amendment to Lease, dated July 1, 2020, by and between Revance Therapeutics, Inc. and BMR-Pacific Research Center LP (Filed With SEC on August 6, 2020)
- Fourth Amendment to Lease, dated May 10, 2018, by and between the Company and BMR-Pacific Research Center LP (Filed With SEC on May 11, 2018)
- THIRD AMENDMENT TO LEASE (Filed With SEC on March 4, 2014)
